Impact of Sofosbuvir ‐Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection

ConclusionDuring the study period reflecting early sofosbuvir use, few liver transplant candidates received sofosbuvir. Use was associated with lower incidence of transplant and a trend toward more waitlist removals due to improved condition.This article is protected by copyright. All rights reserved.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - February 18, 2019 Category: Drugs & Pharmacology Authors: Bethany Dellay, Anne Sexter, Jeffrey H. Wang, Gregory P. Hess, W. Ray Kim, Ajay K. Israni Tags: Original Research Article Source Type: research